TRAVATAN Side Effects

7003241-2 | Dry Eye, Entropion, Eye Irritation, Foreign Body Sensation In Eyes, Growth Of Eyelashes, Trichiasis
on Sep 07, 2010 Female patient from UNITED STATES , 78 years of age, weighting 124.0 lb, was diagnosed with glaucoma (What is glaucoma?) and was treated with Travatan (View Usage). Patient experienced the following unwanted or unexpected effects: dry eye, entropion, eye irritation, foreign body sensation in eyes, growth of eyelashes, trichiasis. Travatan dosage: (1 Gtt Qd Ou Ophthalmic).

6964076-X | Corneal Dystrophy, Disease Progression, Glaucoma
Patient was taking Travatan (View Usage). Patient had the following side effects: corneal dystrophy, disease progression, glaucoma (What is glaucoma?) on Aug 19, 2010 from SWITZERLAND Additional patient health information: Female patient , 45 years of age, was diagnosed with glaucoma (What is glaucoma?) and. Travatan dosage: 1 Gtt Qd Ou, Ophthalmic.

6913520-2 | Eye Disorder, Visual Acuity Reduced, Visual Field Defect
Adverse event was reported on Jul 22, 2010 by a Female patient taking Travatan (View Usage) (Dosage: Ophthalmic) was diagnosed with glaucoma (What is glaucoma?) and. Location: UNITED KINGDOM , 80 years of age, After Travatan was administered, patient had the following side effects: eye disorder, visual acuity reduced, visual field defect. During the same period patient was treated with PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), CHLORAMPHENICOL (View Chloramphenicol Review and Chloramphenicol Label ), XALATAN (View Xalatan Review and Xalatan Label ).

6887580-1 | Hallucination, Visual
on Jul 14, 2010 Female patient from AUSTRALIA , 89 years of age, was treated with Travatan (View Usage). Patient experienced the following unwanted or unexpected effects: hallucination, visual. Travatan dosage: . During the same period patient was treated with PRAVASTATIN (View Pravastatin Review and Pravastatin Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), TEMAZEPAM (View Temazepam Review and Temazepam Label ), VERAPAMIL (View Verapamil Review and Verapamil Label ), CELECOXIB (View Celecoxib Review and Celecoxib Label ), IRBESARTAN (View Irbesartan Review and Irbesartan Label ).


6785155-6 | Eye Pain, Eye Pruritus, Foreign Body Sensation In Eyes, Headache, Lacrimation Increased, Ocular Hyperaemia, Photophobia, Retinitis
on Jun 04, 2010 Male patient from UNITED STATES , 62 years of age, weighting 150.0 lb, was diagnosed with glaucoma (What is glaucoma?), retinal disorder (What is retinal disorder?) and was treated with Travatan (View Usage). Patient had the following side effects: eye pain, eye pruritus, foreign body sensation in eyes, headache (What is headache?), lacrimation increased, ocular hyperaemia, photophobia, retinitis. Travatan dosage: (1 Gtt Bid Ou Ophthalmic), (1 Gtt 1x/3 Days Ou Ophthalmic). During the same period patient was treated with NEVANAC ((ophthalmic)) (View Nevanac Review and Nevanac Label ), PAXIL (View Paxil Review and Paxil Label ), CLONAZEPAM (View Clonazepam Review and Clonazepam Label ), CLOMIPRAMINE (View Clomipramine Review and Clomipramine Label ).

6761388-X | Deafness Transitory, Deafness Unilateral, Tinnitus
Patient was taking Travatan (View Usage). After Travatan was administered, patient had the following side effects: deafness transitory, deafness unilateral, tinnitus (What is tinnitus?) on May 25, 2010 from GERMANY Additional patient health information: Male patient , 54 years of age, was diagnosed with glaucoma (What is glaucoma?) and. Travatan dosage: 1 Gtt Qd Ou, Ophthalmic. During the same period patient was treated with SIMVASTATIN (View Simvastatin Review and Simvastatin Label ). Patient was hospitalized.

6760393-7 | Iris Hyperpigmentation, Melanoma Recurrent
Adverse event was reported on May 19, 2010 by a Male patient taking Travatan (View Usage) (Dosage: (1 Gtt Qd Ou Ophthalmic)) was diagnosed with glaucoma (What is glaucoma?) and. Location: UNITED STATES , 79 years of age, Patient experienced the following unwanted or unexpected effects: iris hyperpigmentation, melanoma recurrent.

6747432-4 | Deafness, Tinnitus
on May 10, 2010 Male patient from GERMANY , 54 years of age, was diagnosed with intraocular pressure increased and was treated with Travatan (View Usage). Patient had the following side effects: deafness, tinnitus (What is tinnitus?). Travatan dosage: Ophthalmic. Patient was hospitalized.

6745175-4 | Eye Swelling, Lip Swelling, Swelling Face, Throat Tightness
on May 11, 2010 Female patient from UNITED STATES , weighting 163.0 lb, was diagnosed with glaucoma (What is glaucoma?) and was treated with Travatan (View Usage). After Travatan was administered, patient had the following side effects: eye swelling, lip swelling, swelling face, throat tightness. Travatan dosage: (1 Gtt Ou Qhs Ophthalmic).

6739545-8 | Iris Hyperpigmentation, Melanoma Recurrent
Patient was taking Travatan (View Usage). Patient experienced the following unwanted or unexpected effects: iris hyperpigmentation, melanoma recurrent on May 11, 2010 from UNITED STATES Additional patient health information: Male patient , 79 years of age, was diagnosed with glaucoma (What is glaucoma?) and. Travatan dosage: (1 Gtt Qd Ou Ophthalmic).

6735242-3 | Angina Pectoris, Chest Pain
Adverse event was reported on May 07, 2009 by a Female patient taking Travatan (View Usage) (Dosage: (ophthalmic)) . Location: UNITED STATES , 75 years of age, Patient had the following side effects: angina pectoris, chest pain (What is chest pain?).

6721129-9 | Deafness, Tinnitus
on Apr 26, 2010 Male patient from GERMANY , 54 years of age, was diagnosed with intraocular pressure increased and was treated with Travatan (View Usage). After Travatan was administered, patient had the following side effects: deafness, tinnitus (What is tinnitus?). Travatan dosage: 1 Gtt Qd Ou. Patient was hospitalized.

6714024-2 | Intraocular Pressure Increased
on Apr 26, 2010 Male patient from GERMANY , 62 years of age, was treated with Travatan (View Usage). Patient experienced the following unwanted or unexpected effects: intraocular pressure increased. Travatan dosage: Ophthalmic. During the same period patient was treated with ATACAND (View Atacand Review and Atacand Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ).

6695351-4 | Product Quality Issue, Sensation Of Foreign Body
Patient was taking Travatan (View Usage). Patient had the following side effects: product quality issue, sensation of foreign body on Apr 23, 2010 from UNITED STATES Additional patient health information: Female patient , 66 years of age, weighting 165.0 lb, was diagnosed with glaucoma (What is glaucoma?) and. Travatan dosage: One Drop In Each Eye Every Night Intraocular.

6694959-X | Facial Palsy, Headache, Skin Hyperpigmentation, Vision Blurred
Adverse event was reported on Apr 08, 2010 by a Female patient taking Travatan (View Usage) (Dosage: Ophthalmic) . Location: FRANCE , 69 years of age, After Travatan was administered, patient had the following side effects: facial palsy, headache (What is headache?), skin hyperpigmentation, vision blurred.

6681918-6 | Ageusia, Anosmia
on Apr 05, 2010 Female patient from BELGIUM , 49 years of age, was diagnosed with ocular hypertension and was treated with Travatan (View Usage). Patient experienced the following unwanted or unexpected effects: ageusia, anosmia. Travatan dosage: 1 Gtt Qd Ou, Ophthalmic. During the same period patient was treated with PROGYNOVA (ESTRADIOL) (View Progynova (estradiol) Review and Progynova (estradiol) Label ).

6656752-3 | Blood Pressure Diastolic Increased, Dizziness, Headache, Sinusitis
on Mar 15, 2010 Female patient from UNITED STATES , 54 years of age, weighting 184.0 lb, was diagnosed with glaucoma (What is glaucoma?) and was treated with Travatan (View Usage). Patient had the following side effects: blood pressure diastolic increased, dizziness (What is dizziness?), headache (What is headache?), sinusitis (What is sinusitis?). Travatan dosage: One Gtt Os Q Hs Ophthalmic.

6654309-1 | Epistaxis
Patient was taking Travatan (View Usage). After Travatan was administered, patient had the following side effects: epistaxis on Mar 09, 2010 from ITALY Additional patient health information: Male patient , 65 years of age, . Travatan dosage: Ophthalmic. During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), ANTIHYPERTENSIVES (ANTIHYPERTENSIVES) (View Antihypertensives (antihypertensives) Review and Antihypertensives (antihypertensives) Label ).

6642771-X | Ageusia
Adverse event was reported on Mar 09, 2010 by a Female patient taking Travatan (View Usage) (Dosage: Qpm, Ophthalmic) was diagnosed with glaucoma (What is glaucoma?) and. Location: GERMANY , 73 years of age, Patient experienced the following unwanted or unexpected effects: ageusia.

6631352-X | Chest Pain, Dyspnoea, Fall, Headache, Visual Impairment
on Mar 11, 2010 Male patient from UNITED STATES , 65 years of age, weighting 220.5 lb, was diagnosed with glaucoma (What is glaucoma?) and was treated with Travatan (View Usage). Patient had the following side effects: chest pain (What is chest pain?), dyspnoea, fall (What is fall?), headache (What is headache?), visual impairment. Travatan dosage: One Drop In Each Eye Nightly Otic. Patient was hospitalized.

6625858-7 | Blood Pressure Diastolic Increased, Dizziness, Sinusitis
on Feb 19, 2010 Female patient from UNITED STATES , 54 years of age, was treated with Travatan (View Usage). After Travatan was administered, patient had the following side effects: blood pressure diastolic increased, dizziness (What is dizziness?), sinusitis (What is sinusitis?). Travatan dosage: (ophthalmic).

6568856-4 | Dehydration, Diarrhoea, Economic Problem, Hypotension, Nausea, Ocular Hyperaemia, Sinusitis, Urinary Tract Infection
Patient was taking Travatan (View Usage). Patient experienced the following unwanted or unexpected effects: dehydration, diarrhoea, economic problem, hypotension, nausea (What is nausea?), ocular hyperaemia, sinusitis (What is sinusitis?), urinary tract infection (What is urinary tract infection?) on Jan 15, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 101.0 lb, was diagnosed with glaucoma (What is glaucoma?) and. Travatan dosage: (ophthalmic). During the same period patient was treated with AZOPT ((ophthalmic)) (View Azopt Review and Azopt Label ), XALATAN ((1 Gtt Ou Ophthalmic)) (View Xalatan Review and Xalatan Label ), NEURONTIN (View Neurontin Review and Neurontin Label ), SYNTHROID (View Synthroid Review and Synthroid Label ), ALBUTEROL (View Albuterol Review and Albuterol Label ), ACETYLSALICYLIC ACID (View Acetylsalicylic Acid Review and Acetylsalicylic Acid Label ), PRAVACHOL (View Pravachol Review and Pravachol Label ).

6428264-3 | Anterior Chamber Inflammation, Condition Aggravated, Corneal Deposits, Detachment Of Retinal Pigment Epithelium, Diabetic Complication, Iritis, Macular Oedema, Maculopathy
Adverse event was reported on Oct 20, 2009 by a Female patient taking Travatan (View Usage) (Dosage: 1 Gtt Qd Ou Ophthalmic) was diagnosed with open angle glaucoma and. Location: JAPAN , 74 years of age, Patient had the following side effects: anterior chamber inflammation, condition aggravated, corneal deposits, detachment of retinal pigment epithelium, diabetic complication, iritis, macular oedema, maculopathy. Patient was hospitalized.

6423772-3 | Fall, Loss Of Consciousness, Orthostatic Hypotension
on Oct 16, 2009 Female patient from FRANCE , 80 years of age, was treated with Travatan (View Usage). After Travatan was administered, patient had the following side effects: fall (What is fall?), loss of consciousness, orthostatic hypotension. Travatan dosage: 1 Df Qd Ophthalmic. During the same period patient was treated with DILTIAZEM (300 Mg Qd) (View Diltiazem Review and Diltiazem Label ), ALPHAGAN (2 Df Bid Ophthalmic) (View Alphagan Review and Alphagan Label ), PRETERAX (BI PREDONIUM) TABLETS TABLET (Oral) (View Preterax (bi Predonium) Tablets Tablet Review and Preterax (bi Predonium) Tablets Tablet Label ), ULTRACET (1 Df Bid) (View Ultracet Review and Ultracet Label ), PRIMPERAN TAB (2 Df Bid) (View Primperan Tab Review and Primperan Tab Label ), OSTRAM (CALCIUM PHOSPHATE) (View Ostram (calcium Phosphate) Review and Ostram (calcium Phosphate) Label ), VALACYCLOVIR HCL (View Valacyclovir Hcl Review and Valacyclovir Hcl Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ). Patient was hospitalized.

6388925-1 | Atrial Fibrillation, Atrial Flutter
on Sep 18, 2009 Male patient from UNITED KINGDOM , 71 years of age, was diagnosed with glaucoma (What is glaucoma?) and was treated with Travatan (View Usage). Patient experienced the following unwanted or unexpected effects: atrial fibrillation (What is atrial fibrillation?), atrial flutter. Travatan dosage: 1 Df Ophthalmic.

6377125-7 | Vision Blurred
Patient was taking Travatan (View Usage). Patient had the following side effects: vision blurred on Sep 23, 2009 from UNITED STATES Additional patient health information: Female patient , 55 years of age, weighting 245.0 lb, was diagnosed with glaucoma (What is glaucoma?) and. Travatan dosage: 1 Drop In Each Eye Nightly Ophthalmic.

6376473-4 | Hair Growth Abnormal
Adverse event was reported on Sep 22, 2009 by a Male patient taking Travatan (View Usage) (Dosage: One Drop Ou Nightly Ophthalmic) was diagnosed with glaucoma (What is glaucoma?) and. Location: UNITED STATES , 68 years of age, weighting 167.0 lb, After Travatan was administered, patient had the following side effects: hair growth abnormal.

6311786-3 | Blepharospasm, Diplopia, Eye Irritation, Visual Acuity Reduced
on Aug 13, 2009 Female patient from UNITED STATES , 48 years of age, weighting 220.0 lb, was diagnosed with eye disorder, glaucoma (What is glaucoma?) and was treated with Travatan (View Usage). Patient experienced the following unwanted or unexpected effects: blepharospasm, diplopia, eye irritation, visual acuity reduced. Travatan dosage: 1 Drop Every Night Ea. Eye.

6284990-0 | Arrhythmia
on Jul 01, 2009 Male patient from NETHERLANDS , 75 years of age, was treated with Travatan (View Usage). Patient had the following side effects: arrhythmia (What is arrhythmia?). Travatan dosage: 1 Gtt Qd Os, Ophthalmic. During the same period patient was treated with TEVETEN (View Teveten Review and Teveten Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), ASCOL (CARBASALATE CALCIUM) (View Ascol (carbasalate Calcium) Review and Ascol (carbasalate Calcium) Label ). Patient was hospitalized.

6268817-9 | Eye Swelling, Lacrimation Increased, Ocular Hyperaemia
Patient was taking Travatan (View Usage). After Travatan was administered, patient had the following side effects: eye swelling, lacrimation increased, ocular hyperaemia on Jul 10, 2009 from UNITED STATES Additional patient health information: Male patient , weighting 205.0 lb, was diagnosed with ocular hypertension and. Travatan dosage: One Drop Once In Evening Ophthalmic.

6202335-9 | Epistaxis, Eye Disorder, Headache, Hypertension, Intraocular Pressure Increased, Mucosal Inflammation, Periorbital Disorder, Rhinalgia
Adverse event was reported on May 07, 2009 by a Female patient taking Travatan (View Usage) (Dosage: Ophthalmic) was diagnosed with glaucoma (What is glaucoma?) and. Location: UNITED STATES , weighting 144.0 lb, Patient experienced the following unwanted or unexpected effects: epistaxis, eye disorder, headache (What is headache?), hypertension, intraocular pressure increased, mucosal inflammation, periorbital disorder, rhinalgia. During the same period patient was treated with LUMIGAN (Ophthalmic) (View Lumigan Review and Lumigan Label ), XALATAN (Ophthalmic) (View Xalatan Review and Xalatan Label ).

6199352-4 | Dysgeusia, Hypertension, Muscular Weakness, Pharyngeal Oedema, Presyncope, Tachycardia
on May 05, 2009 Female patient from BRAZIL , 63 years of age, was diagnosed with glaucoma (What is glaucoma?) and was treated with Travatan (View Usage). Patient had the following side effects: dysgeusia, hypertension, muscular weakness, pharyngeal oedema, presyncope, tachycardia. Travatan dosage: 1 Gtt Ou Ophthalmic. Patient was hospitalized.

6097105-9 | Arrhythmia
on Feb 20, 2009 Female patient from NETHERLANDS , 75 years of age, was treated with Travatan (View Usage). After Travatan was administered, patient had the following side effects: arrhythmia (What is arrhythmia?). Travatan dosage: Ophthalmic. Patient was hospitalized.

6094113-9 | Arrhythmia
Patient was taking Travatan (View Usage). Patient experienced the following unwanted or unexpected effects: arrhythmia (What is arrhythmia?) on Jan 27, 2009 from NETHERLANDS Additional patient health information: Female patient , 75 years of age, . Travatan dosage: Ophthalmic. Patient was hospitalized.

6065986-0 | C-reactive Protein Increased, Conjunctival Hyperaemia, Headache
Adverse event was reported on Jan 16, 2009 by a Male patient taking Travatan (View Usage) (Dosage: Ni, Ophthalmic) was diagnosed with glaucoma (What is glaucoma?) and. Location: FRANCE , 65 years of age, Patient had the following side effects: c-reactive protein increased, conjunctival hyperaemia, headache (What is headache?). During the same period patient was treated with SYSTEMIC SCLERODERMA (View Systemic Scleroderma Review and Systemic Scleroderma Label ). Patient was hospitalized.

5972634-4 | Eye Pain, Mycotic Corneal Ulcer
on Nov 14, 2008 Female patient from JAPAN , 72 years of age, was diagnosed with glaucoma (What is glaucoma?) and was treated with Travatan (View Usage). After Travatan was administered, patient had the following side effects: eye pain, mycotic corneal ulcer. Travatan dosage: 1 Gtt Od Qd. During the same period patient was treated with FLUOROMETHOLONE (FLUOROMETHOLONE) (View Fluorometholone (fluorometholone) Review and Fluorometholone (fluorometholone) Label ).

5963036-5 | Corneal Opacity, Eye Discharge, Eyelid Oedema, Pneumococcal Infection, Ulcerative Keratitis, Visual Acuity Reduced
on Nov 13, 2008 Male patient from JAPAN , 75 years of age, was diagnosed with open angle glaucoma and was treated with Travatan (View Usage). Patient experienced the following unwanted or unexpected effects: corneal opacity, eye discharge, eyelid oedema, pneumococcal infection, ulcerative keratitis, visual acuity reduced. Travatan dosage: 1 Gtt Ou Ed, Ophthalmic. During the same period patient was treated with AZOPT (View Azopt Review and Azopt Label ), HYALEIN (HYALURONATE SODIUM) (View Hyalein (hyaluronate Sodium) Review and Hyalein (hyaluronate Sodium) Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), WARFARIN POTASSIUM (WARFARIN POTASSIUM) (View Warfarin Potassium (warfarin Potassium) Review and Warfarin Potassium (warfarin Potassium) Label ), TICLOPIDINE HCL (View Ticlopidine Hcl Review and Ticlopidine Hcl Label ), MOSAPRIDE CITRATE (MOSAPRIDE CITRATE) (View Mosapride Citrate (mosapride Citrate) Review and Mosapride Citrate (mosapride Citrate) Label ), COLESTILAN (COLESTILAN) (View Colestilan (colestilan) Review and Colestilan (colestilan) Label ), MAGNESIUM OXIDE (MAGNESIUM OXIDE) (View Magnesium Oxide (magnesium Oxide) Review and Magnesium Oxide (magnesium Oxide) Label ). Patient was hospitalized and became disabled.

5957371-4 | Abscess, Bacterial Infection, Cellulitis, Cellulitis Orbital, Corneal Abscess, Corneal Opacity, Eye Discharge, Eye Infection Bacterial, Eye Infection Staphylococcal
Patient was taking Travatan (View Usage). Patient had the following side effects: abscess (What is abscess?), bacterial infection (What is bacterial infection?), cellulitis (What is cellulitis?), cellulitis orbital, corneal abscess, corneal opacity, eye discharge, eye infection bacterial, eye infection staphylococcal on Oct 30, 2008 from JAPAN Additional patient health information: Male patient , 75 years of age, was diagnosed with open angle glaucoma and. Travatan dosage: 1 Gtt Ou Qd; Ophthalmic. During the same period patient was treated with AZOPT (View Azopt Review and Azopt Label ), HYALEIN (HYALURONATE SODIUM) (View Hyalein (hyaluronate Sodium) Review and Hyalein (hyaluronate Sodium) Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), WARFARIN POTASSIUM (WARFARIN POTASSIUM) (View Warfarin Potassium (warfarin Potassium) Review and Warfarin Potassium (warfarin Potassium) Label ), TICLOPIDINE HCL (View Ticlopidine Hcl Review and Ticlopidine Hcl Label ), MOSAPRIDE CITRATE (MOSAPRIDE CITRATE) (View Mosapride Citrate (mosapride Citrate) Review and Mosapride Citrate (mosapride Citrate) Label ), COLESTILAN (COLESTILAN) (View Colestilan (colestilan) Review and Colestilan (colestilan) Label ), MAGNESIUM OXIDE (MAGNESIUM OXIDE) (View Magnesium Oxide (magnesium Oxide) Review and Magnesium Oxide (magnesium Oxide) Label ). Patient was hospitalized and became disabled.

5940367-6 | Bacterial Infection, Cellulitis Orbital, Corneal Opacity, Eye Discharge, Eye Pain, Eyelid Oedema, Pneumococcal Infection, Staphylococcal Infection, Ulcerative Keratitis
Adverse event was reported on Oct 17, 2008 by a Male patient taking Travatan (View Usage) (Dosage: 1 Gtt Ou Qd) was diagnosed with open angle glaucoma and. Location: JAPAN , 75 years of age, After Travatan was administered, patient had the following side effects: bacterial infection (What is bacterial infection?), cellulitis orbital, corneal opacity, eye discharge, eye pain, eyelid oedema, pneumococcal infection, staphylococcal infection (What is staphylococcal infection?), ulcerative keratitis. During the same period patient was treated with AZOPT (View Azopt Review and Azopt Label ), HYALEIN(HYALURANATE SODIUM) (View Hyalein(hyaluranate Sodium) Review and Hyalein(hyaluranate Sodium) Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), WARFARIN POTASSIUM(WARFARIN POTASSIUM) (View Warfarin Potassium(warfarin Potassium) Review and Warfarin Potassium(warfarin Potassium) Label ), TICLOPIDINE HCL (View Ticlopidine Hcl Review and Ticlopidine Hcl Label ), MOSAPRIDE CITRATE(MOSAPRIDE CITRATE) (View Mosapride Citrate(mosapride Citrate) Review and Mosapride Citrate(mosapride Citrate) Label ), COLESTILAN(COLESTILAN) (View Colestilan(colestilan) Review and Colestilan(colestilan) Label ), MAGNESIUM OXIDE(MAGNESIUM OXIDE) (View Magnesium Oxide(magnesium Oxide) Review and Magnesium Oxide(magnesium Oxide) Label ). Patient was hospitalized.

5940353-6 | Macular Oedema
on Oct 15, 2008 Female patient from JAPAN , 73 years of age, was diagnosed with normal tension glaucoma and was treated with Travatan (View Usage). Patient experienced the following unwanted or unexpected effects: macular oedema. Travatan dosage: 1 Gtt Ou Qd. During the same period patient was treated with MEVALOTIN (PREVASTATIN SODIUM) (View Mevalotin (prevastatin Sodium) Review and Mevalotin (prevastatin Sodium) Label ), LOSARTAN POTASSIUM (View Losartan Potassium Review and Losartan Potassium Label ), MEHYCOBAL (CYNAOCOBALAMIN) (View Mehycobal (cynaocobalamin) Review and Mehycobal (cynaocobalamin) Label ), ALFAROL (ALFACALICIDOL) (View Alfarol (alfacalicidol) Review and Alfarol (alfacalicidol) Label ), MERISLON (BETHAISTINE HYDROCHLORIDE) (View Merislon (bethaistine Hydrochloride) Review and Merislon (bethaistine Hydrochloride) Label ), SELBEX (TEPRENONE) (View Selbex (teprenone) Review and Selbex (teprenone) Label ), BIFERMIN(BIOFERMIN) (View Bifermin(biofermin) Review and Bifermin(biofermin) Label ), GANATON(ITOPRIDE HYDROCHLORIDE) (View Ganaton(itopride Hydrochloride) Review and Ganaton(itopride Hydrochloride) Label ).

5932237-4 | Bacterial Infection, Eye Infection Staphylococcal, Pneumococcal Infection, Ulcerative Keratitis
on Oct 08, 2008 Male patient from JAPAN , 75 years of age, was diagnosed with glaucoma (What is glaucoma?) and was treated with Travatan (View Usage). Patient had the following side effects: bacterial infection (What is bacterial infection?), eye infection staphylococcal, pneumococcal infection, ulcerative keratitis. Travatan dosage: Qd Ophthalmic. During the same period patient was treated with AZOPT (View Azopt Review and Azopt Label ), HYALEIN (HYALURONATE SODIUM) (View Hyalein (hyaluronate Sodium) Review and Hyalein (hyaluronate Sodium) Label ). Patient was hospitalized.

5932170-8 | Dizziness, Dyspepsia, Eye Irritation, Gastric Disorder, Growth Of Eyelashes, Hair Growth Abnormal, Nausea
Patient was taking Travatan (View Usage). After Travatan was administered, patient had the following side effects: dizziness (What is dizziness?), dyspepsia, eye irritation, gastric disorder, growth of eyelashes, hair growth abnormal, nausea (What is nausea?) on Oct 06, 2008 from GERMANY Additional patient health information: Female patient , 66 years of age, was diagnosed with glaucoma (What is glaucoma?) and. Travatan dosage: Ou Qd. During the same period patient was treated with AZOPT (View Azopt Review and Azopt Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), ESTRADERM (View Estraderm Review and Estraderm Label ). Patient was hospitalized.

5929186-4 | Abdominal Pain, Anal Haemorrhage, Gastrointestinal Inflammation, Haematochezia, Large Intestinal Ulcer
Adverse event was reported on Oct 06, 2008 by a Male patient taking Travatan (View Usage) (Dosage: 1 Gtt Qd) was diagnosed with glaucoma (What is glaucoma?) and. Location: GERMANY , 68 years of age, Patient experienced the following unwanted or unexpected effects: abdominal pain (What is abdominal pain?), anal haemorrhage, gastrointestinal inflammation, haematochezia, large intestinal ulcer. During the same period patient was treated with CODIOVAN (CO DIOVAN) (View Codiovan (co-diovan) Review and Codiovan (co-diovan) Label ), NEXIUM (ESOMEPRAZOLE SODIUM) (View Nexium (esomeprazole Sodium) Review and Nexium (esomeprazole Sodium) Label ), TAMSULOSIN HCL (View Tamsulosin Hcl Review and Tamsulosin Hcl Label ), AMIODARO (AMIODARONE HYDROCHLORIDE) (View Amiodaro (amiodarone Hydrochloride) Review and Amiodaro (amiodarone Hydrochloride) Label ). Patient was hospitalized.

5912034-6 | Dizziness, Dyspepsia, Gastric Disorder, Growth Of Eyelashes, Hair Growth Abnormal, Nausea, Skin Burning Sensation, Skin Hyperpigmentation
on Sep 23, 2008 Female patient from GERMANY , 66 years of age, was diagnosed with glaucoma (What is glaucoma?) and was treated with Travatan (View Usage). Patient had the following side effects: dizziness (What is dizziness?), dyspepsia, gastric disorder, growth of eyelashes, hair growth abnormal, nausea (What is nausea?), skin burning sensation, skin hyperpigmentation. Travatan dosage: Ou Qd, Ophthalmic. During the same period patient was treated with AZOPT (Ophthalmic) (View Azopt Review and Azopt Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), ESTRADERM (View Estraderm Review and Estraderm Label ). Patient was hospitalized.

5902594-3 | Dizziness, Dyspepsia, Growth Of Eyelashes, Hair Growth Abnormal, Nausea, Skin Burning Sensation, Skin Hyperpigmentation
on Sep 09, 2008 Female patient from GERMANY , 65 years of age, was diagnosed with intraocular pressure increased and was treated with Travatan (View Usage). After Travatan was administered, patient had the following side effects: dizziness (What is dizziness?), dyspepsia, growth of eyelashes, hair growth abnormal, nausea (What is nausea?), skin burning sensation, skin hyperpigmentation. Travatan dosage: Ophthalmic. During the same period patient was treated with LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), ESTRADERM (View Estraderm Review and Estraderm Label ). Patient was hospitalized.

5888812-9 | Asthma, Depression, Headache, Palpitations, Vision Blurred
Patient was taking Travatan (View Usage). Patient experienced the following unwanted or unexpected effects: asthma (What is asthma?), depression (What is depression?), headache (What is headache?), palpitations, vision blurred on Sep 17, 2008 from UNITED STATES Additional patient health information: Female patient , 54 years of age, weighting 226.0 lb, was diagnosed with glaucoma (What is glaucoma?) and. Travatan dosage: 1 Drop Once At Bedtime Ophthalmic, 1 Month 15 Days.

5876086-4 | Anxiety, Arrhythmia, Asphyxia, Asthenia, Bradycardia, Breath Odour, Cardiac Failure, Cough, Depression
Adverse event was reported on Aug 26, 2008 by a Female patient taking Travatan (View Usage) (Dosage: 1 Gtt Ou Qd Ophthalmic) was diagnosed with ocular hypertension and. Location: SPAIN , 80 years of age, Patient had the following side effects: anxiety (What is anxiety?), arrhythmia (What is arrhythmia?), asphyxia, asthenia, bradycardia, breath odour, cardiac failure, cough, depression (What is depression?). During the same period patient was treated with LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), EUTIROX (LEVOTHYROXINE SODIUM) (View Eutirox (levothyroxine Sodium) Review and Eutirox (levothyroxine Sodium) Label ), CALPRES (AMLODIPINE BESILATE) (View Calpres (amlodipine Besilate) Review and Calpres (amlodipine Besilate) Label ), LIPOLAC (CARBOMER) (View Lipolac (carbomer) Review and Lipolac (carbomer) Label ), ZAMENE (DEFLAZACORT) (View Zamene (deflazacort) Review and Zamene (deflazacort) Label ), PANTOPRAZOL (PANTOPRAZOLE SODIUM) (View Pantoprazol (pantoprazole Sodium) Review and Pantoprazol (pantoprazole Sodium) Label ), VALSARTAN (View Valsartan Review and Valsartan Label ). Patient was hospitalized.

5848058-7 | Monoplegia, Transient Ischaemic Attack
on Aug 06, 2008 Female patient from FRANCE , 44 years of age, was diagnosed with ocular hypertension and was treated with Travatan (View Usage). After Travatan was administered, patient had the following side effects: monoplegia, transient ischaemic attack. Travatan dosage: 1 Gtt Qd, Ophthalmic. During the same period patient was treated with CRESTOR (View Crestor Review and Crestor Label ), OROCAL(CALCIUM CARBONATE) (View Orocal(calcium Carbonate) Review and Orocal(calcium Carbonate) Label ), FOSAMAX (View Fosamax Review and Fosamax Label ). Patient was hospitalized.

5821742-7 | Pancreatitis Acute
on Jul 07, 2008 Female patient from BRAZIL , 23 years of age, was diagnosed with glaucoma (What is glaucoma?) and was treated with Travatan (View Usage). Patient experienced the following unwanted or unexpected effects: pancreatitis acute. Travatan dosage: 1 Gtt Ou Qd Ophthalmic. Patient was hospitalized.

5797900-7 | Pancreatitis Acute
Patient was taking Travatan (View Usage). Patient had the following side effects: pancreatitis acute on Jun 16, 2008 from BRAZIL Additional patient health information: Female patient , 23 years of age, was diagnosed with glaucoma (What is glaucoma?) and. Travatan dosage: 1 Gtt Ou Qd Ophthalmic. Patient was hospitalized.